关注
Teh-Ia Huo
Teh-Ia Huo
在 vghtpe.gov.tw 的电子邮件经过验证
标题
引用次数
引用次数
年份
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
JC Wu, YH Huang, GY Chau, CW Su, CR Lai, PC Lee, TI Huo, IJ Sheen, ...
Journal of hepatology 51 (5), 890-897, 2009
4882009
Sero‐clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
T Huo, J Wu, P Lee, G Chau, W Lui, S Tsay, L Ting, F Chang, S Lee
Hepatology 28 (1), 231-236, 1998
3281998
Gastrointestinal and liver manifestations in patients with COVID-19
IC Lee, TI Huo, YH Huang
Journal of the Chinese Medical Association 83 (6), 521-523, 2020
3122020
Molecular pathogenesis of human hepatocellular carcinoma
XW Wang, SP Hussain, TI Huo, CG Wu, M Forgues, LJ Hofseth, C Brechot, ...
Toxicology 181, 43-47, 2002
3122002
Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients
CW Su, YH Huang, TI Huo, HH Shih, IJ Sheen, SW Chen, PC Lee, ...
Gastroenterology 130 (6), 1625-1635, 2006
2872006
Prognosis of hepatocellular carcinoma: assessment of eleven staging systems
PH Liu, CY Hsu, CY Hsia, YH Lee, CW Su, YH Huang, FY Lee, HC Lin, ...
Journal of hepatology 64 (3), 601-608, 2016
2752016
Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and …
TI Huo, JC Wu, HC Lin, FY Lee, MC Hou, PC Lee, FY Chang, SD Lee
Journal of hepatology 42 (6), 826-832, 2005
2382005
Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system
CY Hsu, YH Lee, CY Hsia, YH Huang, CW Su, HC Lin, RC Lee, YY Chiou, ...
Hepatology 57 (1), 112-119, 2013
2082013
Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D
JC Wu, TZ Chen, TI Huo, SD Lee, KB Choo, CM Chen
The Lancet 346 (8980), 939-941, 1995
2061995
A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System
CY Hsu, YH Huang, CY Hsia, CW Su, HC Lin, CC Loong, YY Chiou, ...
Journal of hepatology 53 (1), 108-117, 2010
1922010
Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice
J Chao, TI Huo, HY Cheng, JC Tsai, JW Liao, MS Lee, XM Qin, MT Hsieh, ...
PloS one 9 (6), e96969, 2014
1882014
Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma≤ 2 cm in a propensity score model
PH Liu, CY Hsu, CY Hsia, YH Lee, YH Huang, YY Chiou, HC Lin, TI Huo
Annals of surgery 263 (3), 538-545, 2016
1862016
Model for end‐stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis
TI Huo, YW Wang, YY Yang, HC Lin, PC Lee, MC Hou, FY Lee, SD Lee
Liver International 27 (4), 498-506, 2007
1772007
Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas
HH Hung, YY Chiou, CY Hsia, CW Su, YH Chou, JH Chiang, WY Kao, ...
Clinical Gastroenterology and Hepatology 9 (1), 79-86, 2011
1752011
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma
CY Hsia, TI Huo, SY Chiang, MF Lu, CL Sun, JC Wu, PC Lee, CW Chi, ...
European Journal of Surgical Oncology (EJSO) 33 (2), 208-212, 2007
1652007
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era
PH Liu, CY Hsu, CY Hsia, YH Lee, YY Chiou, YH Huang, FY Lee, HC Lin, ...
Journal of gastroenterology and hepatology 32 (4), 879-886, 2017
1602017
Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis
TI Huo, XW Wang, M Forgues, CG Wu, EA Spillare, C Giannini, C Brechot, ...
Oncogene 20 (28), 3620-3628, 2001
1432001
Proposal of a modified Child‐Turcotte‐Pugh scoring system and comparison with the model for end‐stage liver disease for outcome prediction in patients with cirrhosis
TI Huo, HC Lin, JC Wu, FY Lee, MC Hou, PC Lee, FY Chang, SD Lee
Liver transplantation 12 (1), 65-71, 2006
1422006
Selecting an optimal prognostic system for liver cirrhosis: the model for end‐stage liver disease and beyond
TI Huo, SD Lee, HC Lin
Liver International 28 (5), 606-613, 2008
1402008
External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan
BL Yang, WC Wu, KC Fang, YC Wang, TI Huo, YH Huang, HI Yang, ...
PloS one 10 (3), e0120443, 2015
1352015
系统目前无法执行此操作,请稍后再试。
文章 1–20